DUSA is a vertically integrated dermatology company that is developing and marketing Levulan® We devote most of our resources to advancing the development and marketing of our Levulan® PDT technology platform. In addition to our marketed products, our drug, Levulan® brand of aminolevulinic acid HCl, or ALA, in combination with light, has been studied in a broad range of medical conditions. When Levulan® is used and followed with exposure to light to treat a medical condition, it is known as Levulan®
Company profile
Ticker
DUSA
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
223103129
DUSA stock data
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
12 Jun 20
CT ORDER
Confidential treatment order
7 Jan 20
CT ORDER
Confidential treatment order
26 Dec 19
CT ORDER
Confidential treatment order
26 Dec 19
CT ORDER
Confidential treatment order
26 Dec 19
CT ORDER
Confidential treatment order
22 Jan 18
CT ORDER
Confidential treatment order
22 Jan 18
CT ORDER
Confidential treatment order
22 Jan 18
CT ORDER
Confidential treatment order
18 Jul 17
CT ORDER
Confidential treatment order
5 Jan 17
Latest ownership filings
SC 13D/A
SUN PHARMACEUTICAL INDUSTRIES LTD
26 Dec 12
SC 13D
Caraco Acquisition Corp
19 Nov 12
SC 13D/A
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
26 May 11
SC 13D/A
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
18 Apr 11
SC 13D/A
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
8 Apr 11
SC 13D/A
SRB Management, L.P.
13 May 10
SC 13D
SRB Management, L.P.
8 Apr 10
SC 13D
SRB Management, L.P.
26 Feb 10
Institutional ownership, Q2 2021
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 10.00 k |
Total shares | 277.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Capital Directions Investment Advisors | 277.00 | $10.00 k |